Absci announces inducement grant under nasdaq listing rule 5635(c)(4)

Vancouver, wash. and new york, july 03, 2024 (globe newswire) -- absci corporation (nasdaq: absi), a data-first generative ai drug creation company, today announced that on july 1, 2024, the company granted a non-statutory stock option to purchase an aggregate of 613,000 shares of its common stock to ms. shelby walker in connection with her employment as absci's chief legal officer. the inducement grant was previously approved by absci's board of directors pursuant to absci's 2023 inducement plan (the “inducement plan”), and is being made as an inducement material to ms. walker's acceptance of employment with the company in accordance with nasdaq listing rule 5635(c)(4).
ABSI Ratings Summary
ABSI Quant Ranking